Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: dalroi who wrote (477)	6/30/1999 8:31:00 PM
From: Eric Freeman	Respond to of 3158

Anyone interested in Biotech should have their eyes on Cytogen. Read the article on PSMA - July 1, 1999 issue. PSMA will make Cytogen move into the focus of Biotech attention. The history: 300 million plus spent on research - poor management - $30 to under $1. Its turning around without PSMA - with it, who knows how high it will go. But there isn't any doubt that they are on to something big. Do your own research, you will not regret it. Cytogen, CYTO Hey its a tout, but its real. Eric